Edition:
United Kingdom

Achieve Life Sciences Inc (ACHV.OQ)

ACHV.OQ on NASDAQ Stock Exchange Capital Market

3.48USD
6:14pm BST
Change (% chg)

$0.03 (+0.87%)
Prev Close
$3.45
Open
$3.42
Day's High
$3.50
Day's Low
$3.41
Volume
10,557
Avg. Vol
105,964
52-wk High
$52.80
52-wk Low
$3.30

Chart for

About

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company engaged in the development and commercialization of cytisine for smoking cessation. The Company’s focus is to address the global smoking health epidemic, which is the leading cause of preventable death and is responsible for nearly six million deaths annually... (more)
No analyst recommendations are available for .

Overall

Beta: 1.95
Market Cap(Mil.): $22.44
Shares Outstanding(Mil.): 10.95
Dividend: --
Yield (%): --

Financials

  ACHV.OQ Industry Sector
P/E (TTM): -- 85.48 32.76
EPS (TTM): -3.70 -- --
ROI: -76.22 2.29 14.61
ROE: -76.41 3.86 16.34

BRIEF-Achieve Qtrly Basic And Diluted Net Loss Per Share $0.24

* QTRLY BASIC AND DILUTED NET LOSS PER SHARE $0.24 Source text for Eikon: Further company coverage:

09 May 2018

BRIEF-Achieve Announces Patent Granted On Novel Formulation Of Cytisine

* ACHIEVE ANNOUNCES PATENT GRANTED ON NOVEL FORMULATION OF CYTISINE Source text for Eikon: Further company coverage:

07 May 2018

BRIEF-Achieve Life Sciences Inc Qtrly Loss Per Share ‍$0.32​

* ACHIEVE LIFE SCIENCES INC QTRLY LOSS PER SHARE ‍$0.32​ Source text for Eikon: Further company coverage:

01 Mar 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $129.01 +4.32
Novartis AG (NOVN.S) CHF78.20 -0.46
Pfizer Inc. (PFE.N) $37.64 +0.26
Roche Holding Ltd. (ROG.S) CHF232.00 -0.25
Roche Holding Ltd. (RO.S) CHF236.80 +0.20
Merck & Co., Inc. (MRK.N) $62.64 +0.05
Bayer AG (BAYGn.DE) €93.41 +0.24
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €71.84 +0.18
Eli Lilly And Co (LLY.N) $89.74 +0.67

Earnings vs. Estimates